Détail de l'auteur
Auteur S. GHISLANDI |
Documents disponibles écrits par cet auteur (5)
Ajouter le résultat dans votre panier
Visionner les documents numériques
Faire une suggestion Affiner la recherche
Article
Health policy-makers worldwide have adopted different Reference Pricing (RP) systems for pharmaceuticals. Systems may differ concerning their effects on pharmaceutical prices, firms? strategies, market structure, public and private expenditure, [...]Document de travail
S. GHISLANDI ; Università Commerciale Luigi Bocconi. Econpubblica Centre for Research on the Public Sector. Milan. ITA | Rochester : Social Science Electronic Publishing | 2009In a pharmaceuticals Reference Price Scheme (RPS), firms are free to set their prices, but the (insured) consumer pays only the difference between the Reference level (R) and the actual price of the drug, if this is higher than R.By introducing [...]Article
Article
Article
S. GHISLANDI ; P. ARMENI ; C. JOMMI |The generic reference price (GRP) was introduced in Italy in 2001. The main purpose of this paper is: (a) producing evidence regarding the effect of GRP on prices; (b) testing the hypothesis that there is a reallocation of demand from the generi[...]